ReviewJACC. Basic to translational science2016

A Phase I, Single Ascending Dose Study of Cimaglermin Alfa (Neuregulin 1β3) in Patients With Systolic Dysfunction and Heart Failure.

Daniel J Lenihan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.